SCM:NYSEStellus Capital Investment Corporation Analysis
Data as of 2026-04-30 - not real-time
$9.56
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Stellus Capital Investment Corp (SCM) is trading below its 20‑day and 50‑day simple moving averages (≈$9.57 and $9.64) and well under the 200‑day SMA (~$12.24), signaling a bearish price environment. The RSI sits near 48, indicating neutral momentum, while the MACD histogram has turned positive (bullish signal) but the overall trend remains down‑trend. Support is identified around $8.82 and resistance near $10.21, with the current price of $9.56 perched just above the support zone. Valuation metrics show a trailing P/E of 10 versus an industry average of 17.5 and a P/B of 0.75, suggesting the stock is materially undervalued. However, the dividend payout ratio exceeds 160% and operating cash flow is negative, raising questions about dividend sustainability despite the eye‑catching 15% yield. The balance sheet is highly leveraged (debt‑to‑equity >170) and the 30‑day volatility exceeds 30%, contributing to a pronounced risk profile.
The consensus analyst rating is “hold” with a median price target of $11.5, implying roughly 20% upside potential. Given the blend of undervaluation, strong dividend appeal, and elevated leverage, investors should weigh short‑term price weakness against medium‑term upside opportunities while monitoring cash‑flow and debt metrics closely.
The consensus analyst rating is “hold” with a median price target of $11.5, implying roughly 20% upside potential. Given the blend of undervaluation, strong dividend appeal, and elevated leverage, investors should weigh short‑term price weakness against medium‑term upside opportunities while monitoring cash‑flow and debt metrics closely.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages and near support
- Neutral RSI with modest bullish MACD histogram
- High dividend payout ratio and negative operating cash flow
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount relative to industry peers
- Attractive dividend yield despite sustainability concerns
- Upside potential indicated by analyst price targets and upside/downside metric
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated leverage and debt‑to‑equity ratio
- Potential for dividend adjustments if cash‑flow constraints persist
- Stable sector fundamentals and low geographic concentration
Key Metrics & Analysis
Financial Health
Revenue Growth-1.60%
Profit Margin26.48%
P/E Ratio10.1
ROE7.30%
ROA4.33%
Debt/Equity175.61
P/B Ratio0.7
Op. Cash Flow$-24449764
Free Cash Flow$23.7M
Industry P/E17.5
Technical Analysis
TrendBearish
RSI47.8
Support$8.82
Resistance$10.21
MA 20$9.57
MA 50$9.64
MA 200$12.24
MACDBullish
VolumeStable
Fear & Greed Index87.84
Valuation
Target Price$11.00
Upside/Downside15.06%
GradeUndervalued
TypeValue
Dividend Yield15.48%
Risk Assessment
Beta0.70
Volatility33.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.